The 1-year cumulative CRC risk in patients with f-Hb 10–19 μg Hb/g faeces and IDA may exceed 3% (based on the upper 95% CI bound of 5.7%) in patients aged >55 years (figure 4). Here, GSTM1 is linked to colorectal carcinoma.